XENETIC BIOSCIENCES INC (XBIO) Forecast, Price Target & Analyst Ratings
NASDAQ:XBIO • US9840156023
2.75 USD
+0.18 (+7%)
Last: Mar 13, 2026, 12:50 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XENETIC BIOSCIENCES INC (XBIO).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateMar 16, 2026
PeriodQ4 / 2025
EPS Estimate-$0.53
Revenue Estimate703.8K
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $2.75 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
XBIO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about XBIO.
In the previous month the buy percentage consensus was at a similar level.
XBIO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-09 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-04-11 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 16, 2026
PeriodQ4 / 2025
EPS Estimate-$0.53
Revenue Estimate703.8K
Revenue Q2Q8.61%
EPS Q2Q22.00%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
XBIO is expected to report earnings on 3/16/2026. The consensus EPS estimate for the next earnings is -0.53 USD and the consensus revenue estimate is 703.80K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.71M 47.41% | 2.54M 48.54% | 2.5M -1.56% | 2.55M 1.99% | 3.06M 20.00% | 2.55M -16.67% | |
| EBITDA YoY % growth | N/A -20.63% | -4.516M 34.89% | N/A -40.04% | -3.468M 45.16% | -6.12M -76.47% | -9.69M -58.33% | |
| EBIT YoY % growth | -6.72M -16.87% | -4.516M 32.80% | -3.5M 22.49% | -3.468M 0.91% | -6.12M -76.47% | -9.69M -58.33% | |
| Operating Margin | -392.98% | -177.78% | -139.98% | -136.00% | -200.00% | -380.00% | |
| EPS YoY % growth | -4.70 -737.79% | -2.75 41.49% | -2.57 6.55% | -2.08 19.04% | -3.39 -62.75% | -0.35 89.76% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.53 22.00% |
| Revenue Q2Q % growth | 703.8K 8.61% |
| EBITDA Q2Q % growth | -918K 57.14% |
| EBIT Q2Q % growth | -918K 16.48% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.09%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.35%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-15.29%
EBIT Next 5 Year
N/A
XENETIC BIOSCIENCES INC / XBIO Forecast FAQ
Can you provide the upcoming earnings date for XENETIC BIOSCIENCES INC?
XENETIC BIOSCIENCES INC (XBIO) will report earnings on 2026-03-16, after the market close.
What are the consensus estimates for XBIO stock next earnings?
The consensus EPS estimate for the next earnings of XENETIC BIOSCIENCES INC (XBIO) is -0.53 USD and the consensus revenue estimate is 703.80K USD.
How many analysts cover XENETIC BIOSCIENCES INC (XBIO) stock?
The number of analysts covering XENETIC BIOSCIENCES INC (XBIO) is 6.